• Tatjana Šimurina, Marija Danilović Luketić, Sandra Graf Župčić, and Boris Mraović.
• 1Department of Anesthesiology, Resuscitation, Intensive Medicine and Pain Management, Faculty of Medicine, Josip Juraj Strossmayer University of Osijek, Osijek, Croatia; 2Department of Health Studies, University of Zadar, Zadar, Croatia; 3Department of Anesthesiology, Resuscitation and Intensive Care Medicine, Zadar General Hospital, Zadar, Croatia; 4Department of Anesthesiology, Resuscitation and Intensive Care Medicine, Požega General County Hospital, Požega, Croatia; 5School of Medicine, University of Rijeka, Rijeka, Croatia; 6Department of Neurology, Rijeka University Hospital Center, Rijeka, Croatia; 7Department of Anesthesiology and Perioperative Medicine, School of Medicine, University of Missouri, Columbia, USA.
• Acta Clin Croat. 2021 Dec 1; 60 (4): 749-757.

AbstractOne of the most common surgeries in elderly patients is eye surgery. An increasing number of patients undergoing ambulatory eye surgery are on antithrombotic therapy. These drugs may increase the risk of perioperative bleeding associated with ophthalmic needle blocks and/or eye surgery. Intraoperative bleeding and postoperative hemorrhagic complications may lead to the loss of vision or even eyes. On the other hand, stopping anticoagulants and antiplatelets before the surgery may increase the risk of thrombotic events with potentially life-threatening complications. The aim of this narrative review is to provide a systematic review of the published evidence for the perioperative antithrombotic management of patients undergoing different types of eye surgery in ambulatory settings. A comprehensive review of the English-language medical literature search utilizing PubMed, Ovid Medline® and Google Scholar from January 2015 to December 2018 was performed. The database searches included studies providing evidence relevant to ambulatory eye surgery and perioperative antiplatelet medications and anticoagulants. Updated recommendations will be given for continuation, discontinuation, and modification of antithrombotic agents in order to optimize the management of antithrombotic therapies in outpatients scheduled for eye surgery.

18 keywords...

hide…